Skip to content

APOTHEEK NEVEJAN

Active Private limited companyfounded 2022active for 4 yearsZeelaan 46, 8660 De PanneKBO/BCE: BE 0786.445.811

Lifetime

3 annual accounts with figures on one time axis
peak of €205,271 in 2023
€86,526▼ 57.3%
peak of €89,153 in 2023
€11,855▼ 85.4%
peak of €182,932 in 2025
€182,932▲ 6.9%
€534,978▼ 10.6%
peak of 0.1 FTE in 2025
0.1 FTE 
Board1 name since 2023
1 director
Documentsfilings and deeds
25-06-202636 days before the deadline
2025abbreviated format
Gross margin from €202,508 to €86,526Result from €80,924 to €11,855

Key points

from the 2025 annual accounts

Result

€11,855 ▼ 85.4%
€80,9002024€11,9002025

The result fell in 2025 from €80,924 to €11,855.

Turnover

≈ €420,000 estimated

The abbreviated format states no turnover.

Debts

€534,978 75% of the balance sheet
Financial debts 78%Suppliers 10%Taxes and wages 1%Other 11%

Of this, €227,081 falls due within a year.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,544 companies had the same profile as APOTHEEK NEVEJAN has now. Each dot stands for 7 companies, two years later.

94.9%
were still trading
1.3%
stopped another way
3.7%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 10 to 30%
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,544 companies, not a prediction for APOTHEEK NEVEJAN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 25-05-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0786445811
First establishment Zeelaan 46, De Panne
Incorporation Founded by · Founding capital of €1,000, 100 shares · published on 25-05-2022 · Gazette deed
All 8 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK NEVEJAN De Panne €717,910 €86,526 25.5% 0.1
PHARMACIE GURNÉ Flémalle €624,135 €119,375 14.9% 0.1
TILIA FARMA Bree €873,139 €102,314 17.4% 0
PHARMACIE VERCOUTER Estinnes €953,184 €72,278 9.3% 0
PHARMACIE SAINT LEO NORD Liège €693,245 €98,047 -2.6% 0.6
CASSIFARMA Leuven €942,826 €114,699 42.3% 0
Pharma Derasse BSI Braine-l'Alleud €762,819 €125,226 15.9% 0.6

These companies have the same main activity as APOTHEEK NEVEJAN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €624,000 and €953,000, founded between 2019 and 2023.

Official details

Source: KBO
Status
Active since 23-05-2022Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.331.562.7698660 De Panne, since 01-06-2022
Financial year end
31 December
Peppol
Reachable since 23-09-2026
Company details

Annual accounts 2025

€717,910▼ 6.7%
Filing
Filed on 25-06-2026, 36 days before the end of the filing period
Financials

Insights on APOTHEEK NEVEJAN

APOTHEEK NEVEJAN files the abbreviated format. That format states no turnover. The gross margin fell from €205,271 in 2023 to €86,526 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK NEVEJAN

What is the company number of APOTHEEK NEVEJAN?
The company number of APOTHEEK NEVEJAN is 0786.445.811. The VAT number is the same number with BE in front: BE 0786.445.811.
Where is APOTHEEK NEVEJAN based?
The registered office is at Zeelaan 46, 8660 De Panne.Company details
What does APOTHEEK NEVEJAN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK NEVEJAN?
APOTHEEK NEVEJAN is a private limited company (BV).
When was APOTHEEK NEVEJAN founded?
APOTHEEK NEVEJAN was founded on 23-05-2022.
Is APOTHEEK NEVEJAN still active?
Yes, APOTHEEK NEVEJAN is an active enterprise in the KBO register.
How many employees does APOTHEEK NEVEJAN have?
APOTHEEK NEVEJAN had an average of 0.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK NEVEJAN?
The turnover in financial year 2025 is about €420,000. This figure is estimated from the gross margin of €86,526 and 77 comparable companies (NACE 477). It probably lies between €210,000 and €610,000.
Is APOTHEEK NEVEJAN profitable?
In financial year 2025, APOTHEEK NEVEJAN made a profit of €11,855.
Where can I find the annual accounts of APOTHEEK NEVEJAN?
APOTHEEK NEVEJAN filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK NEVEJAN due?
APOTHEEK NEVEJAN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.